P

Priovant Therapeutics

Clinical-stage biotech delivering autoimmune therapies

Associate Clinical Operations

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeUnited StatesNo salary listed

About the Job

Requirements

  • A bachelor's degree is required; a scientific or technical discipline is preferred.
  • At least 2 years of clinical research experience is required; 3–4 years is ideal.
  • Strong organizational skills and the ability to manage multiple tasks and competing priorities are required.
  • The candidate must be collaborative and able to work well in small teams.
  • The candidate must be extremely detail-oriented.
  • The candidate must be flexible to travel when needed, potentially supporting up to two on-site visits each month.
  • The candidate must be able to learn quickly and respond well to feedback.
  • Proficiency with Excel, PowerPoint, and project management software such as Monday.com is required.

Responsibilities

  • Develop and maintain a system for organizing and tracking essential documents related to study start-up and execution.
  • Serve as the first-round reviewer of investigational product release checklists, ensuring that essential study documents meet compliance standards before site activation.
  • Support timely execution of clinical development goals by managing and maintaining key study metrics related to monitoring and data quality.
  • Help manage site-level interactions with external vendors, including troubleshooting site issues.
  • Support the clinical monitoring team by co-monitoring on key programs.
  • Facilitate tracking of operational on-study workflows, such as protocol amendment implementation and patient re-consenting.
  • Provide ad hoc support for clinical operations workstreams across programs.

About the Company

Priovant Therapeutics

Clinical-stage biotech delivering autoimmune therapies

Priovant Therapeutics focuses on developing medicines for autoimmune diseases that carry the heaviest patient burden. It is in the clinical-stage phase, building a pipeline of therapies that specifically target the molecular problems driving severe autoimmune conditions. This approach aims to address patients who are underserved by current treatments. The company’s treatments work by focusing on the underlying molecular dysregulations to reduce disease activity and improve outcomes, rather than broadly suppressing the immune system. Priovant differentiates itself by prioritizing severe, underserved autoimmune diseases and pursuing targeted, mechanism-based therapies rather than one-size-fits-all drugs. The goal is to bring new, effective options to patients who lack good treatment choices and to move promising therapies through clinical development toward patient access.

Company size
51-200
Company stage
Not listed
Total funding
Not listed
Headquarters
New York City, United States
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Priovant Therapeutics

See more jobs